Francisco T. P.
- Country
- Spain
- Department
- Servicio de Microbiología Clínica y enfermedades Infecciosas
Research Overview
- Efficacy and Safety of Islatravir and Ulonivirine Once Weekly versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Once Daily in Treatment-Naïve Adults with HIV-1
- Evaluation of AZD3152 and Cilgavimab for Pre-exposure Prophylaxis of COVID-19 in Immunocompromised Patients: A Randomized, Double-blind, Phase I/III Study
- A Phase 2b Randomized, Open-Label Active Controlled Study Evaluating the Safety and Efficacy of oral VH4524184 Coadministered with Emtricitabine and Tenofovir Alafenamide in Treatment Naïve Viremic Persons with HIV-1.( INNOVATE Study)
Data & Insights
Has run more than one trial at 19 of 104 partner sites.
Specializations
Infectious Disease Prevention
The investigator specializes in preventive strategies against COVID-19, with particular focus on novel prophylactic approaches using monoclonal antibodies.
- Pre-exposure prophylaxis development
- Viral variant response studies
- Antibody-based interventions
Expertise extends to evaluating protective measures against emerging viral variants and immunological prevention strategies.
Clinical Safety Assessment
This investigator conducts comprehensive safety evaluations of novel therapeutic antibodies, focusing on preventive applications in infectious diseases.
- Safety profile analysis
- Therapeutic monitoring
- Risk assessment protocols
Specialized in evaluating the safety parameters of prophylactic interventions in at-risk populations.
Therapeutic Efficacy
The investigator focuses on comparative efficacy assessment of prophylactic treatments, particularly in preventing symptomatic viral infections.
- Comparative treatment analysis
- Prevention effectiveness
- Clinical outcomes evaluation
Specializes in measuring therapeutic effectiveness against various viral strain manifestations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.